z-logo
open-access-imgOpen Access
Lower versus Traditional Treatment Threshold for Neonatal Hypoglycemia
Author(s) -
Anne Van Kempen,
P. Frank Eskes,
Debbie H. G. M. Nuytemans,
Johanna H. van der Lee,
Lea M. Dijksman,
Nicole R. van Veenendaal,
Flip J. P. C. M. van der Hulst,
Rob Moonen,
Luc J. I. Zimmermann,
Ellen P. van ’t Verlaat,
Minouche van Dongen-van Baal,
Ben A. Semmekrot,
Hélène G. Stas,
Ron H.T. van Beek,
José J. Vlietman,
Peter H. Dijk,
J. Termote,
Rogier C.J. de Jonge,
Amerik C. de Mol,
Marianne W. A. Huysman,
Joke H. Kok,
Martin Offringa,
Nicole Boluyt
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1905593
Subject(s) - hypoglycemia , neonatal hypoglycemia , medicine , pregnancy , insulin , biology , gestation , gestational diabetes , genetics
Worldwide, many newborns who are preterm, small or large for gestational age, or born to mothers with diabetes are screened for hypoglycemia, with a goal of preventing brain injury. However, there is no consensus on a treatment threshold that is safe but also avoids overtreatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom